Predictors of persistence of social anxiety disorder: A national study

Department of Psychiatry, New York State Psychiatric Institute and College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.
Journal of Psychiatric Research (Impact Factor: 3.96). 08/2011; 45(12):1557-63. DOI: 10.1016/j.jpsychires.2011.08.004
Source: PubMed


Social anxiety disorder (SAD) is highly prevalent and impairing. Little is known about rates and predictors of persistence of SAD in the community. The current study derived data from the National Epidemiologic Survey on Alcohol and Related Conditions, Wave 1 (2001-2002, n = 43,093) and Wave 2 (2004-2005, n = 34,653), a large survey of a representative sample of the United States adult population. Individuals with current DSM-IV SAD at Wave 1 were re-interviewed 3 years later at Wave 2 using the Alcohol Use Disorder and Associated Disabilities Interview Schedule-DSM IV Version (AUDADIS-IV). We found that in the community, 22.3% of respondents with SAD at the Wave 1 evaluation met DSM-IV criteria for SAD three years later, and endorsement of social interaction fears and a higher number of avoided social situations, treatment-seeking during past year, and comorbidity with mood disorders independently predicted persistence of SAD. These results suggest that persistence of SAD in the community is common and associated with symptom severity and comorbid mood disorders.

Download full-text


Available from: Mayumi Okuda
    • "SAD tends to first present and intensify in later adolescence (e.g., Alfano et al. 2006; Kuusikko et al. 2008), which is how the lower age limit of 16 was determined. The upper age limit of 45 was chosen because results from several national surveys suggest that social anxiety symptoms tend to wane when individuals reach their mid-40s (e.g., Blanco et al. 2011; Ruscio et al. 2008). However, it is important to note that these national surveys did not focus on individuals with ASD, and the course of SAD in adults with ASD is currently unknown. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Social anxiety symptoms are common among cognitively unimpaired youth with autism spectrum disorder (ASD). Few studies have investigated the co-occurrence of social anxiety disorder (SAD) in adults with ASD, although identification may aid access to effective treatments and inform our scientific efforts to parse heterogeneity. In this preliminary study, we examined the clinical presentation of SAD in adults with ASD (n = 28), relative to SAD uncomplicated by ASD (n = 26). A large subset (50 %) of the adults with ASD met diagnostic criteria for SAD. The adults with ASD plus SAD differed from those with ASD without SAD on several characteristics. Findings demonstrate that many adults with ASD are aware of their social difficulties and experience impairing social anxiety.
    No preview · Article · Aug 2015 · Journal of Autism and Developmental Disorders
  • Source
    • "We found that 87.5% of individuals with CMDD at baseline had remitted three years later. Our rates are slightly higher than the 40–60% rates of remission of CMDD one year after psychopharmacologic or psychotherapeutic treatment in clinical samples (Klein et al., 2009; Nemeroff et al., 2003; Rhebergen et al., 2012), but in line with other prospective studies that have documented high rates of remission of other often chronic psychiatric disorders, such as dysthymia (Rubio et al., 2013) and social anxiety disorder (Blanco et al., 2011). The higher rates in our study are likely due to the longer follow-up period as well as the inclusion of nontreatment-seeking individuals, who tend to have lower severity and better long-term prognosis than those from clinical populations Table 2 Risk factors. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Chronic major depressive disorder (CMDD) is highly prevalent and associated with high personal and societal cost. Identifying risk factors for persistence and remission of CMDD may help in developing more effective treatment and prevention interventions. Prospective cohort study of individuals participating in the National Epidemiologic Survey on Alcohol and Related Conditions (Wave 1; n=43,093) and its 3-year follow-up (Wave 2; n=34,653) who met a diagnosis of CMDD at the Wave 1 assessment. Among the 504 respondents who met criteria for present CMDD at Wave 1, only 63 (11.52%) of them continued to meet criteria of CMDD. A history of childhood sexual abuse, earlier onset of MDD, presence of comorbidity and a history of treatment-seeking for depression predicted persistence of CMDD three years after the baseline evaluation. Our sample is limited to adults, our follow-up period was only three-years and the diagnosis of CMDD at baseline was retrospective. CMDD shows high rates of remission within three years of baseline assessment, although some specific risk factors predict a persistent course. Given the high personal and societal cost associated with CMDD, there is a need to develop and disseminate effective interventions for CMDD.
    Full-text · Article · Jul 2013 · Journal of Affective Disorders
  • [Show abstract] [Hide abstract]
    ABSTRACT: The comorbidity between psychiatric and substance use disorders remains an important phenomenon to understand, and an active area of investigation. The purpose of this review is to highlight key 2011 issues and novel findings on psychiatric and substance disorders comorbidity from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), a large national survey of the US general population. Topics of active investigation included the internalizing/externalizing meta-structure of common mental disorders; the 10 Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) personality disorders; the 3-year incidence and persistence of disorders; treatment of major depression; and many other topics not as easily categorized. Meta-structure may increasingly offer a parsimonious way of addressing comorbidity, although adding new disorders adds complexity and the value of etiologic analyses utilizing broad dimensions of psychopathology rather than individual disorders is not yet fully known. Expanding the range of personality disorders beyond antisocial personality disorder appears essential in understanding the incidence and persistence of substance use disorders. Substance use disorders have low rates of treatment relative to major depression, but increase the likelihood of depression treatment among comorbid cases, a phenomenon that needs to be understood. These comorbidity studies provide much novel information, and indicate many potentially fruitful directions for new research.
    No preview · Article · Mar 2012 · Current opinion in psychiatry
Show more